EXPORTING ISRAELI CANNABIS INNOVATION
CIITECH partners with leading institutions and companies in Israel and the UK to leverage cutting-edge cannabis science and clinical research. Our mission is to craft unique cannabis therapeutic products that can help a wide range of indications.
Our vision is to contribute to the future where people are free to choose between physician prescribed cannabinoid-based pharmaceuticals or nutraceutical & wellness products on recommendation & anecdotal evidence.
WHAT WE DO
CIITECH has partnered with the leading Israeli academic institution for cannabinoid research.
Good product develops by understanding the profile and behaviour of the hundreds of molecules found in the cannabis plant. Through science, we gain clarity to advance towards effective products.
CIITECH’s partners include leading Israeli scientists and pharmaceutical experts.
Together with our UK production partner, we are creating new and novel cannabinoid formulations for the wellness market with the precision and consistency of clinically validated medicine.
CIITECH identifies innovative & optimal delivery mechanisms for cannabinoid bioavailability.
We have partnered with an Israeli based medical cannabis biotech company to bring the UK and Europe a high-quality, safe and reliable medical grade vaporizer, suitable for CBD and CBG.
RESEARCH & FOCUS
CIITECH is investigating a wide spectrum of minor cannabinoids and combination profiles for multiple application and delivery mechanisms. Our initial studies will focus on the use of cannabigerol (CBG) as primary molecule.
Whilst potential medical applications are wide ranging, our areas of focus are; dermatalogical, digestive and neurological disorders.
ADHD & Migraine together with related neurological conditions
Obesity & Diabetes together with related metabolism disorders.
Psoriasis & Eczema together with related dermatological conditions
Cannabigerol. CBG is a non-psychoactive cannabinoid. CBG is the genetic precursor molecule to all subsequent cannabinoids (THC, CBD, +).
Combinations. Testing the entourage effects of combining cannabinoids, terpenoids and other known molecules.
ISRAEL: 00972 (0)54 808 6559
UK: 0044 (0)203 734 7764